Two-year oral IL-23 data, GLP-1 biomarker findings, and a nonsurgical option for superficial basal cell carcinoma headline the sessions covered in Las Vegas.
|Videos|January 26, 2022
Linda Stein Gold, MD, Talks Psoriasis in 2022
Author(s)Katie Hobbins
Linda Stein Gold, MD, discusses psoriasis in 2022, in her presentation at the current Maui Derm for Dermatologists meeting.
Advertisement
Psoriasis was a hot topic at the current Maui Derm for Dermatologist meeting, held in Maui, Hawaii. In the presentation, “Psoriasis Update: 2022” Linda Stein Gold, MD, director of clinical research and division head of the Department of Dermatology at Henry Ford Hospital in Detroit, Michigan, discussed the challenges in mild to moderate psoriasis, including exciting oral and topical therapies.
Advertisement
Related to this article
Doral Fredericks, PharmD, MBA, discusses how life stages, mental health, and reproductive concerns can shape dermatologic care for women.
The approval expands the IL-23 inhibitor’s indications beyond moderate-to-severe plaque psoriasis to include adults with active psoriatic arthritis.
Elevate-Derm Summer 2026 faculty share practical lessons on hair loss exams, PIH, geriatric dermatology, and managing cholesterol rises on JAK inhibitors.
Updated SKYRIZI labeling allows clinicians to use clinical judgment when determining the need for TB evaluation before treatment.
Experts outline how to recognize undertreated psoriasis, assess incomplete response, and make individualized decisions when escalating therapy.
ORKA-001 achieved PASI 100 in 61% of high-dose patients at week 16 in the phase 2b EVERLAST-B trial of moderate-to-severe psoriasis.
The 3rd annual meeting in Atlanta gives dermatology NPs and PAs 4 case-based breakout sessions and a general education session in a focused, small-group setting.
Advertisement
Advertisement
Trending on Dermatology Times
1
AADA Warns of 6% Medicare Payment Cut for Dermatologists in 2027
2
Don't Be Rash: Navigating Topical Steroid Withdrawal Concerns in Pediatric Eczema
3
Bone Alkaline Phosphatase and Growth in Pediatric Atopic Dermatitis
4
Systemic Therapy Selection in Pediatric and Adult Atopic Dermatitis
5